Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2905 | 2039 | 51.5 | 84% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1833 | 5655 | GLUCOSE TRANSPORTER//WARBURG EFFECT//GLUT1 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | WARBURG EFFECT | Author keyword | 74 | 38% | 8% | 156 |
2 | PKM2 | Author keyword | 71 | 72% | 3% | 56 |
3 | 3 BROMOPYRUVATE | Author keyword | 54 | 68% | 2% | 48 |
4 | TUMOR M2 PYRUVATE KINASE | Author keyword | 53 | 95% | 1% | 18 |
5 | TUMOR M2 PK | Author keyword | 34 | 93% | 1% | 13 |
6 | PYRUVATE KINASE M2 | Author keyword | 33 | 71% | 1% | 27 |
7 | TKTL1 | Author keyword | 29 | 88% | 1% | 14 |
8 | CANCER METABOLISM | Author keyword | 28 | 33% | 3% | 68 |
9 | AEROBIC GLYCOLYSIS | Author keyword | 25 | 34% | 3% | 61 |
10 | GLUTAMINOLYSIS | Author keyword | 23 | 43% | 2% | 41 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | WARBURG EFFECT | 74 | 38% | 8% | 156 | Search WARBURG+EFFECT | Search WARBURG+EFFECT |
2 | PKM2 | 71 | 72% | 3% | 56 | Search PKM2 | Search PKM2 |
3 | 3 BROMOPYRUVATE | 54 | 68% | 2% | 48 | Search 3+BROMOPYRUVATE | Search 3+BROMOPYRUVATE |
4 | TUMOR M2 PYRUVATE KINASE | 53 | 95% | 1% | 18 | Search TUMOR+M2+PYRUVATE+KINASE | Search TUMOR+M2+PYRUVATE+KINASE |
5 | TUMOR M2 PK | 34 | 93% | 1% | 13 | Search TUMOR+M2+PK | Search TUMOR+M2+PK |
6 | PYRUVATE KINASE M2 | 33 | 71% | 1% | 27 | Search PYRUVATE+KINASE+M2 | Search PYRUVATE+KINASE+M2 |
7 | TKTL1 | 29 | 88% | 1% | 14 | Search TKTL1 | Search TKTL1 |
8 | CANCER METABOLISM | 28 | 33% | 3% | 68 | Search CANCER+METABOLISM | Search CANCER+METABOLISM |
9 | AEROBIC GLYCOLYSIS | 25 | 34% | 3% | 61 | Search AEROBIC+GLYCOLYSIS | Search AEROBIC+GLYCOLYSIS |
10 | GLUTAMINOLYSIS | 23 | 43% | 2% | 41 | Search GLUTAMINOLYSIS | Search GLUTAMINOLYSIS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TU M2 PK | 110 | 93% | 2% | 41 |
2 | PYRUVATE KINASE M2 | 104 | 57% | 6% | 124 |
3 | AEROBIC GLYCOLYSIS | 83 | 32% | 11% | 219 |
4 | PKM2 | 58 | 83% | 2% | 33 |
5 | GLUTAMINE METABOLISM | 36 | 24% | 6% | 132 |
6 | WARBURG | 33 | 49% | 2% | 49 |
7 | KIDNEY TYPE GLUTAMINASE | 31 | 73% | 1% | 24 |
8 | LDH A | 31 | 92% | 1% | 12 |
9 | 3 BROMOPYRUVATE | 28 | 69% | 1% | 24 |
10 | M2 PYRUVATE KINASE | 26 | 51% | 2% | 37 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
PKM2 contributes to cancer metabolism | 2015 | 7 | 85 | 67% |
Targeting cellular metabolism to improve cancer therapeutics | 2013 | 136 | 115 | 54% |
Pyruvate kinase M2 and cancer: an updated assessment | 2014 | 15 | 84 | 80% |
Metabolic pathways promoting cancer cell survival and growth | 2015 | 4 | 100 | 42% |
Impact of MYC in regulation of tumor cell metabolism | 2015 | 3 | 90 | 44% |
Links between metabolism and cancer | 2012 | 213 | 126 | 35% |
Tumor suppressor p53 and its mutants in cancer metabolism | 2015 | 5 | 67 | 27% |
Regulation of cancer cell metabolism | 2011 | 797 | 132 | 31% |
The Warburg effect in tumor progression: Mitochondrial oxidative metabolism as an anti-metastasis mechanism | 2015 | 3 | 85 | 39% |
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation | 2008 | 966 | 73 | 27% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | WINSHIP CANC EMORY | 5 | 60% | 0.3% | 6 |
2 | REGULATORY ENVIRONM ANALYT METABOL | 5 | 42% | 0.5% | 10 |
3 | BIOCHEM ENDOCRINOL | 5 | 24% | 0.9% | 18 |
4 | GASTROINTESTINAL GLAND SURG | 4 | 75% | 0.1% | 3 |
5 | GEN SURG S | 4 | 75% | 0.1% | 3 |
6 | MED TRASLAC | 4 | 75% | 0.1% | 3 |
7 | CELL BIOL R 124 | 3 | 100% | 0.1% | 3 |
8 | HIGHTECH SUZHOU | 3 | 60% | 0.1% | 3 |
9 | QUIM PROT | 2 | 13% | 0.8% | 16 |
10 | BIOL MOLISCIII | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000182677 | GLUT 1//GLUCOSE TRANSPORTER 1//GLUT 1 EXPRESSION |
2 | 0.0000088261 | T CELL METABOLISM//UAB MITOCHONDRIAL MED//BZ 423 |
3 | 0.0000088132 | MOL BASIS MITOCHONDRIAL DIS GRP//MITOCHONDRIAL GENET GRP//STEM CELL METABOLISM |
4 | 0.0000086455 | LACTATE TRANSPORT//MONOCARBOXYLATE TRANSPORTER//MONOCARBOXYLATE TRANSPORTERS |
5 | 0.0000073431 | SESTRIN 2//TP53INP1//SESTRIN |
6 | 0.0000070132 | PYRUVATE KINASE DEFICIENCY//PYRUVATE KINASE//PK LR GENE |
7 | 0.0000067587 | LONIDAMINE//IONIDAMINE//ADVANCED BREAST CANCER CHEMOTHERAPY |
8 | 0.0000064730 | FATTY ACID SYNTHASE//C75//CERULENIN |
9 | 0.0000059384 | VDAC//MITOCHONDRIAL PORIN//VOLTAGE DEPENDENT ANION SELECTIVE CHANNEL |
10 | 0.0000054593 | AMMONIAGENESIS//CELLULAR GLUTAMATE//RABBIT KIDNEY CORTEX TUBULES |